Group items tagged

Precision medicine is based on knowing the effects of certain gene mutations (changes).

High prevalence of cancer is expected to aid in growth of the monoclonal antibody therapeutics market. According to the American Cancer Society, in 2019, there will be an estimated 1,762,450 new cancer cases diagnosed and 606,880 cancer deaths in the U.S. Monoclonal immunotherapy is a successful form of immunotherapy, which makes use of monoclonal antibodies to bind to a specific antigen in cells which are specific to that disease.

Single-domain antibodies also referred to as nanobodies, is an antibody molecule consisting of only a single monomeric protein domain. Like a whole virus, it can bind to and inhibit the replication of a certain antigen. As the name suggests, single-Domain antibodies are made from antibodies that have the ability to bind to a single protein or DNA nanorespondage, limiting the proliferation of that protein or DNA nanorespondage.

Protein hydrolysate components are peptides that are generated from proteins. Protein hydrolysates have a higher protein content and are absorbed faster than other proteins. Milk protein hydrolysate and beef protein hydrolysate are two types of protein hydrolysate components. The antigenic characteristics of these protein hydrolysate components are rather modest. Protein hydrolysates components improve digestibility and minimise protein allergy, particularly in newborns.